Cargando…

Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma

Detalles Bibliográficos
Autores principales: Mailhot Vega, Raymond B., Castellino, Sharon M., Pei, Qinglin, Parsons, Susan, Roberts, Kenneth B., Hodgson, David, Charpentier, Anne-Marie, Fitzgerald, Thomas J., Kessel, Sandy K., Keller, Frank G., Kelly, Kara, Hoppe, Bradford S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Particle Therapy Co-operative Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768892/
https://www.ncbi.nlm.nih.gov/pubmed/35127976
http://dx.doi.org/10.14338/IJPT-21-00012.1
_version_ 1784635018057875456
author Mailhot Vega, Raymond B.
Castellino, Sharon M.
Pei, Qinglin
Parsons, Susan
Roberts, Kenneth B.
Hodgson, David
Charpentier, Anne-Marie
Fitzgerald, Thomas J.
Kessel, Sandy K.
Keller, Frank G.
Kelly, Kara
Hoppe, Bradford S.
author_facet Mailhot Vega, Raymond B.
Castellino, Sharon M.
Pei, Qinglin
Parsons, Susan
Roberts, Kenneth B.
Hodgson, David
Charpentier, Anne-Marie
Fitzgerald, Thomas J.
Kessel, Sandy K.
Keller, Frank G.
Kelly, Kara
Hoppe, Bradford S.
author_sort Mailhot Vega, Raymond B.
collection PubMed
description
format Online
Article
Text
id pubmed-8768892
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Particle Therapy Co-operative Group
record_format MEDLINE/PubMed
spelling pubmed-87688922022-02-03 Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma Mailhot Vega, Raymond B. Castellino, Sharon M. Pei, Qinglin Parsons, Susan Roberts, Kenneth B. Hodgson, David Charpentier, Anne-Marie Fitzgerald, Thomas J. Kessel, Sandy K. Keller, Frank G. Kelly, Kara Hoppe, Bradford S. Int J Part Ther Editorial The Particle Therapy Co-operative Group 2021-10-28 /pmc/articles/PMC8768892/ /pubmed/35127976 http://dx.doi.org/10.14338/IJPT-21-00012.1 Text en ©Copyright 2021 The Author(s) https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed in accordance with Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ).
spellingShingle Editorial
Mailhot Vega, Raymond B.
Castellino, Sharon M.
Pei, Qinglin
Parsons, Susan
Roberts, Kenneth B.
Hodgson, David
Charpentier, Anne-Marie
Fitzgerald, Thomas J.
Kessel, Sandy K.
Keller, Frank G.
Kelly, Kara
Hoppe, Bradford S.
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
title Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
title_full Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
title_fullStr Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
title_full_unstemmed Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
title_short Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
title_sort evaluating disparities in proton radiation therapy use in ahod1331, a contemporary children's oncology group trial for advanced-stage hodgkin lymphoma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768892/
https://www.ncbi.nlm.nih.gov/pubmed/35127976
http://dx.doi.org/10.14338/IJPT-21-00012.1
work_keys_str_mv AT mailhotvegaraymondb evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT castellinosharonm evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT peiqinglin evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT parsonssusan evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT robertskennethb evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT hodgsondavid evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT charpentierannemarie evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT fitzgeraldthomasj evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT kesselsandyk evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT kellerfrankg evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT kellykara evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma
AT hoppebradfords evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma